• Ibrutinib-Induced Atrial Fibrillation: The Role of C-Src Kin

  2026-07-09

  The reference study reveals that atrial fibrillation (AF) associated with ibrutinib therapy arises from off-target inhibition of C-terminal Src kinase (CSK), not Bruton tyrosine kinase (BTK). This mechanistic insight highlights the need for selective kinase inhibition in cancer therapies and informs the design of safer targeted inhibitors.

• Pentoxifylline Dampens Hyperinflammatory Responses in Preter

  2026-07-08

  Schüller et al. deliver the first detailed in vitro characterization of pentoxifylline’s (PTX) immunomodulatory effects on LPS-stimulated monocytes from preterm infants. Their findings highlight age-dependent suppression of key surface activation markers, pro-inflammatory cytokines, and TLR4 signaling, clarifying PTX's potential as adjunct therapy in neonatal sepsis.

• Pentoxifylline: Phosphodiesterase Inhibitor in Inflammation

  2026-07-08

  Pentoxifylline is a non-specific phosphodiesterase inhibitor that elevates intracellular cAMP, suppresses pro-inflammatory cytokines, and downregulates monocyte ICAM-1 expression. These properties underpin its utility as an anti-inflammatory and immunomodulatory agent in both in vitro and in vivo research. Application parameters and mechanistic benchmarks are well established for translational models.

• Balsalazide Disodium: Targeted Prodrug Strategy for Ulcerati

  2026-07-07

  This review examines the innovation and clinical significance of balsalazide disodium as a colon-targeted prodrug for ulcerative colitis. The reference study demonstrates improved remission induction, favorable safety, and rapid onset relative to conventional 5-ASA agents, with implications for both mechanistic inflammation research and translational applications.

• Isolation and Characterization of Baicalin Methyl Ester from

  2026-07-07

  The reference study isolated and structurally characterized two new flavone 2'-glucosides and seven known phenolics, including baicalin methyl ester, from the roots of Scutellaria baicalensis. These findings provide a foundational chemical map for subsequent mechanistic research and practical exploration of baicalin derivatives in models of intestinal barrier dysfunction and inflammation.

• Pomalidomide (CC-4047): Protocols and Innovations for Myelom

  2026-07-06

  Pomalidomide (CC-4047) is redefining hematological malignancy research by enabling precise modulation of the tumor microenvironment and robust inhibition of pro-tumor cytokines. This article provides actionable protocol recommendations, advanced troubleshooting strategies, and insight into leveraging mutational landscape data for optimized experimental design.

• Mitochondrial Apoptosis in Ovarian Cancer-Related Muscle Atr

  2026-07-06

  This study reveals that inhibiting mitochondrial-linked apoptosis via the antioxidant SkQ1 does not prevent skeletal muscle atrophy in a metastatic ovarian cancer mouse model. The findings decouple mitochondrial ROS-driven apoptotic signaling from muscle wasting in type II B fibers, challenging prior assumptions about the causal role of apoptosis and necroptosis in cancer cachexia.

• Z-IETD-FMK: Deep Dive into Caspase-8 Inhibition for Immune M

  2026-07-05

  Explore how Z-IETD-FMK, a specific caspase-8 inhibitor, advances immune cell activation research and apoptosis assays. This article uniquely connects mechanistic insights to practical assay design, offering an evidence-based guide for immunology and cell biology laboratories.

• Procainamide Hydrochloride in Cardiac and Oncology Research

  2026-07-04

  Procainamide Hydrochloride bridges cardiac electrophysiology and oncology, offering unique workflow advantages as both a sodium channel blocker and DNMT1 inhibitor. This guide translates the latest reference breakthroughs—like its chemoprotective synergy with cisplatin—into actionable protocols and troubleshooting strategies for advanced preclinical research.

• Applied Workflows with PP 1: Src Family Tyrosine Kinase Inhi

  2026-07-03

  PP 1 empowers researchers with nanomolar precision in dissecting Src family kinase-driven pathways, enabling reliable modeling of cancer progression and immune modulation. This article delivers actionable protocol enhancements, troubleshooting insights, and cross-study comparisons that elevate experimental design and interpretability.

• Procainamide Hydrochloride in Cardiac and Oncology Research

  2026-07-03

  Procainamide Hydrochloride is redefining cardiac electrophysiology and oncology workflows through its dual-action as a sodium channel blocker and epigenetic modulator. Discover optimized protocols, troubleshooting strategies, and new combinatorial assay designs that maximize data reproducibility and translational impact.

• BX795 as a PDK1 Inhibitor: Protocols for Cancer & Immunity

  2026-07-02

  BX795 enables precise and reproducible interrogation of the PI3K/Akt/mTOR axis and innate immune signaling in both cancer and immunology workflows. This guide details experimental protocols, troubleshooting strategies, and innovative use-cases leveraging APExBIO’s BX795 for robust kinase pathway analysis.

• 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine:

  2026-07-02

  Unlock robust immune rejection modulation with 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine, a selective α2-adrenergic receptor agonist optimized for hydrogel-based delivery and post-surgery osteosarcoma recurrence research. This guide details experimental workflows, troubleshooting nuances, and actionable insights from the latest research on α2-AR signaling.

• Rapamycin (Sirolimus): Protocol Optimization & Applied Use-C

  2026-07-01

  Rapamycin (Sirolimus) is a gold-standard mTOR inhibitor with unparalleled specificity, enabling mechanistic clarity in cancer, immunology, and disease modeling studies. This article delivers actionable protocols, troubleshooting strategies, and highlights a novel workflow from recent autophagy research to maximize reproducibility and translational value.

• Balsalazide Disodium Dihydrate: Colonic Delivery and Researc

  2026-07-01

  Explore the unique colonic activation and translational research advantages of Balsalazide Disodium Dihydrate, a prodrug of 5-aminosalicylic acid. This article uncovers mechanistic insights and protocol strategies that extend beyond standard inflammation research.

8574 records 15/572 page Previous Next First page 上5页 1112131415 下5页 Last page